Publication: COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
dc.contributor.author | Ferrandis, Raquel | |
dc.contributor.author | Llau, Juan V. | |
dc.contributor.author | Quintana, Manuel | |
dc.contributor.author | Sierra, Pilar | |
dc.contributor.author | Hidalgo, Francisco | |
dc.contributor.author | Cassinello, Concepción | |
dc.contributor.author | Gómez-Luque, Aurelio | |
dc.contributor.authoraffiliation | [Ferrandis,R] Anaesthesiology and Critical Care Service, University Hospital La Fe, Valencia, Spain. [Llau,JV] Anaesthesiology and Critical Care Service, University Hospital Doctor Peset, Valencia, Spain. [Quintana,M] Intensive Medicine Service, University Hospital La Paz-Carlos III, Madrid, Spain. [Sierra,P] Anaesthesiology and Critical Care Service, Fundació Puigvert, Barcelona, Spain. [Hidalgo,F] Anaesthesiology and Critical Care Service, Clínica Universidad de Navarra, Pamplona, Spain. [Cassinello,C] Anaesthesiology and Critical Care Service, University Hospital Miguel Servet, Zaragoza, Spain. [Gómez-Luque,A] Anaesthesiology and Critical Care Service, University Hospital Virgen de la Victoria, Málaga, Spain. | |
dc.date.accessioned | 2021-03-04T12:13:35Z | |
dc.date.available | 2021-03-04T12:13:35Z | |
dc.date.issued | 2020-06-11 | |
dc.description.version | Yes | es_ES |
dc.format.extent | 3 p. | es_ES |
dc.identifier.citation | Ferrandis R, Llau JV, Quintana M, Sierra P, Hidalgo F, Cassinello C, et al. COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients? Crit Care. 2020 Jun 11;24(1):332. | es_ES |
dc.identifier.doi | 10.1186/s13054-020-03052-9 | es_ES |
dc.identifier.essn | 1466-609X | |
dc.identifier.issn | 1364-8535 | |
dc.identifier.pmc | PMC7289223 | |
dc.identifier.pmid | 32527286 | es_ES |
dc.identifier.uri | http://hdl.handle.net/10668/3250 | |
dc.journal.title | Critical Care | |
dc.language.iso | en | |
dc.publisher | BioMed Central Ltd. | es_ES |
dc.relation.publisherversion | https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03052-9 | es_ES |
dc.rights.accessRights | open access | |
dc.subject | COVID-19 | es_ES |
dc.subject | Coronavirus infections | es_ES |
dc.subject | Thromboprophylaxis | es_ES |
dc.subject | SARS-CoV-2 | es_ES |
dc.subject | Anticoagulants | es_ES |
dc.subject | Critical Illness | es_ES |
dc.subject.mesh | Medical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Hematologic Agents::Anticoagulants | es_ES |
dc.subject.mesh | Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Critical Illness | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Carbohydrates::Polysaccharides::Glycosaminoglycans::Heparin::Heparin, Low-Molecular-Weight | es_ES |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es_ES |
dc.subject.mesh | Medical Subject Headings::Health Care::Environment and Public Health::Public Health::Disease Outbreaks::Epidemics::Pandemics | es_ES |
dc.subject.mesh | Medical Subject Headings::Diseases::Cardiovascular Diseases::Vascular Diseases::Embolism and Thrombosis::Embolism::Pulmonary Embolism | es_ES |
dc.subject.mesh | Medical Subject Headings::Diseases::Cardiovascular Diseases::Vascular Diseases::Embolism and Thrombosis::Thromboembolism::Venous Thromboembolism | es_ES |
dc.title | COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients? | es_ES |
dc.type | letter | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Ferrandis_COVID19.pdf
- Size:
- 472.34 KB
- Format:
- Adobe Portable Document Format
- Description:
- Letter